News
Feed
Events
Feed
News
+ Events
Feed

Vivoryon Therapeutics N.V.

  • ISIN NL00150002Q7
  • Land Deutschland

Aktuelle News

28 November 2022

13:30 Corporate EN

Vivoryon Therapeutics N.V.

Corporate
EN

Vivoryon Therapeutics N.V.: Vivoryon Therapeutics to Present a Clinical Update on its Novel Oral Small Molecule Varoglutamstat at Clinical Trials on Alzheimer’s Disease Conference (CTAD)

23 November 2022

07:00 Corporate EN

Vivoryon Therapeutics N.V.

Corporate
EN

Vivoryon Therapeutics N.V.: Vivoryon Therapeutics Announces Successful Listing of 2,054,796 Shares (news with additional features)

22 November 2022

07:20 Corporate EN

Vivoryon Therapeutics N.V.

Corporate
EN

Vivoryon Therapeutics N.V.: Vivoryon Therapeutics N.V. Reports Third Quarter 2022 Financial Results and Highlights Operational Progress (news with additional features)

14 November 2022

07:00 Corporate EN

Vivoryon Therapeutics N.V.

Corporate
EN

Vivoryon Therapeutics N.V.: Vivoryon Therapeutics N.V. to Report Q3 2022 Financial Results and Operational Progress on November 22, 2022

30 September 2022

08:47 Corporate EN

Vivoryon Therapeutics N.V.

Corporate
EN

Vivoryon Therapeutics N.V.: Vivoryon Therapeutics N.V. Reports H1 2022 Financial Results and Highlights Operational Progress (news with additional features)

08:45 Corporate EN

Vivoryon Therapeutics N.V.

Corporate
EN

Vivoryon Therapeutics N.V.: Vivoryon Therapeutics Announces Successful Private Placement of up to EUR 30 Million (news with additional features)